Clinical Trials
3 trialsNCT02885974 2025-07-28
BLAST
Baylor College of Medicine
Phase 1 Completed
NCT00084578 2013-07-15
Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder
Fox Chase Cancer Center
Phase NA Withdrawn
NCT00006124 2013-02-13
Celecoxib in Treating Patients With Bladder Cancer
National Cancer Institute (NCI)
Phase 2/3 Completed